Among 12 tumors of BRCA carriers, eight were the HER2‐negative luminal‐B, two were the HER2‐positive luminal‐B subtype, and two unclassified (whose breast cancer was diagnosed in 1992 and 2003, and the result of hormonal receptor and HER2 were not available). Here, ERBB2 is linked to breast cancer.